Rhythm Pharmaceuticals OverviewRhythm Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for RYTM.
Quarterly Other Income/Expense
-$2.73M
↓ 13.21% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$4.34M
↓ 207.15% YoY
Trailing 12 months ending Mar 31, 2026